课题基金 / 基金详情

A Fundamental Study of Molecular and Developmental Pathology for Prevention and Treatment of Perinatal Hypoxic-Ischemic Brain Damage

A Fundamental Study of Molecular and Developmental Pathology for Prevention and Treatment of Perinatal Hypoxic-Ischemic Brain Damage
围产期缺氧缺血性脑损伤防治的分子与发育病理学基础研究
批准号:
13671147
负责人:
ITO Masayuki
金额:
$2.18万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

ITO Masayuki的其他基金

相似基金

相关文献

中文摘要
翻译
我们研究了一种细胞凋亡现象及其在新生儿缺氧缺血性脑损伤(HIE)中的作用。结果表明,细胞凋亡在围产期HIE的形成中起重要作用。受试者采用以下方法获得。2周龄小鼠在乙醚麻醉下假手术结扎颈总动脉5分钟。术后1 ~ 14天取出研究材料。脑组织采用苏木精-伊红染色、缺口末端标记(TUNEL)、免疫组化(IHC)和原位杂交(ISH)染色。结果显示,术后第7天,TUNEL检测细胞凋亡数量明显增加。c-fos和bcl-2家族蛋白及mRNA表达在术后3 d达到高峰。新生儿HIE的发病机制有待进一步研究。
英文摘要
We studied an apoptosis phenomenon and its role on neonatal hypoxic-ischemic brain damage (HIE). From our results, we revealed apoptosis was an important role on forming perinatal HIE.The subjects were obtained by the below method. Two-weeks old mice were performed sham-operation and 5-minites ligation of common carotid arteries under ether anesthesia. At one to 14 days after operation, the research materials were removed.The brain tissue were stained with hematoxyline-eosin, nick end-labeling (TUNEL), immunohistochemistry (IHC) and in situ hybrydization (ISH).The results showed the number of apoptosis, which were detected by TUNEL, increased to 7 days after operation. And on the concerning of the protein and mRNA expression of c-fos and bcl-2 family, the peak was 3 days after operation.The furthermore studies are needed to clarify the pathomechanism of neonatal HIE.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Motonaga K, Itoh M, Becker LE, Goto Y, Takashima S: "levated expression of beta-site amyloid precursor protein cleaving enzyme 2 in brains of patients with Down syndrome"Neuroscience Letter. 326. 64-66 (2002)
Motonaga K、Itoh M、Becker LE、Goto Y、Takashima S:“唐氏综合症患者大脑中 β 位点淀粉样蛋白前体蛋白裂解酶 2 的表达升高”《神经科学快报》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Motonaga K, Itoh M, Becker LE, Goto Y, Takashima S.: "levated expression of beta-site amyloid precursor protein cleaving enzyme 2 in brains of patients with Down syndrome"Neuroscience Letter. 326. 64-66 (2002)
Motonaga K、Itoh M、Becker LE、Goto Y、Takashima S.:“唐氏综合症患者大脑中 β 位点淀粉样蛋白前体蛋白裂解酶 2 的表达升高”《神经科学快报》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Motonaga K, Itoh M, Hirayama A, Hirano S, Becker LE, Goto Y, Takashima S: "Up-regulation of E2F-1 in Down' s syndrome brain exhibiting neuropathological features of Alzheimer-type dementia"Brain Reserch. 905. 250-253 (2001)
Motonaga K、Itoh M、Hirayama A、Hirano S、Becker LE、Goto Y、Takashima S:“唐氏综合症大脑中 E2F-1 的上调,表现出阿尔茨海默型痴呆的神经病理学特征”大脑研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hirayama A, Oka A, Itoh M, Tanaka F, Okoshi Y, Takashima S.: "Myelin transcription factor 1 (MyT1) immunoreactivity in infants with periventricular leukomalacia"Developmental Brain Research. 140. 85-92 (2003)
Hirayyama A、Oka A、Itoh M、Tanaka F、Okoshi Y、Takashima S.:“脑室周围白质软化症婴儿的髓磷脂转录因子 1 (MyT1) 免疫反应性”发育性脑研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
8
    An exploration of causative genes of focal cortical dysplasia with intractable epilepsy, using advanced technologies
    • 批准号:
      22659197
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.1万
    • 财政年份:
      2010
    • 负责人:
      ITO Masayuki
    • 依托单位:
    A molecular study of methyl-CpG binding protein 2 (MeCP2) dysfunction leaded to Rett syndrome phenotype
    THE STUDY OF NON-LINEAR PHENOMENA BY THE ASYMPTOTIC ANALYSIS
    • 批准号:
      11640124
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.11万
    • 财政年份:
      1999
    • 负责人:
      ITO Masayuki
    • 依托单位:
    THE MATHEMATICAL ANALYSIS TO NON-LINEAR PHENOMENA THROUGH NON-LINEAR PARTIAL DIFFERENTIAL EQUATIONS
    • 批准号:
      09640276
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.98万
    • 财政年份:
      1997
    • 负责人:
      ITO Masayuki
    • 依托单位:
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位:
    双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
    • 批准号:
      81670594
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2016
    • 负责人:
      陈昊
    • 依托单位:
    Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
    • 批准号:
      81470791
    • 项目类别:
      面上项目
    • 资助金额:
      73.0万元
    • 批准年份:
      2014
    • 负责人:
      董家鸿
    • 依托单位: